|
Market Closed -
Saudi Arabian S.E.
13:20:00 27/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 64.75 SAR | +2.05% |
|
+9.19% | +1.90% |
| 11:47am | Avalon Pharma Reiterated at Overweight as Aljazira Capital Notes 'Solid' Q2 Growth | MT |
| 08-20 | Avalon Pharma Renews SAR50 Million Credit Facility | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bearish |
| Resistance | 64.91 | 66.46 | 66.46 |
| Spread/Res. | -0.25% | -2.57% | -2.57% |
| Spread/Supp. | +6.94% | +9.75% | +16.58% |
| Support | 60.55 | 59 | 55.54 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 4016 Stock
- Charts Middle East Pharmaceutical Industries Company
Select your edition
All financial news and data tailored to specific country editions
